Chongqing Claruvis Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chongqing Claruvis Pharmaceutical Co., Ltd., explained in plain language.
-
New injection aims to loosen paralyzed arms in stroke survivors
Disease control Recruiting nowThis study is testing a new formulation of botulinum toxin (called YY001) to see if it can safely reduce severe muscle stiffness in the arm of adults who have had a stroke. About 254 participants will receive injections to see how well the treatment relaxes their tight muscles an…
Phase: PHASE2, PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New treatment tested to loosen paralyzed arms
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of repeated injections of a new botulinum toxin (YY001) for adults with stiff, tight arm muscles (spasticity) after a stroke. It aims to see if multiple treatments over time can safely reduce muscle tightness and improv…
Phase: PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC